METHOD OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERS

Abstract: the disclosure is related to a method of treating a disorder, such as prader willi syndrome (pws), obesity or hyperphagia, in a subject using a melanocortin-4 receptor (mc4r) agonist. also described is method of treating a subject having a deficiency in the pro-opiomelanocortin (pomc)-mc4r pathway, such as a pomc-null or a pcsk-null subject, using a mc4r agonist.

Inventor(s): Leonardus H.T. Van Der Ploeg, Bart T. Henderson, Peter Kuhnen

CPC Classification: A61K38/12 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))

Search for rejections for patent application number 20250195606